United States Biotechnology & Medical Research

Tourmaline Bio Inc (TRML)

Track

Track

Ticker: TRML Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tourmaline Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
MCDADE MARK Non-Executive Director
Transaction date
Purchase
Price
202.93
Quantity 18,004 -1.5%
Value US$4,823,918
3.9
Thiara Parvinder Non-Executive Director
Transaction date
Purchase
Price
17.31
Quantity 1,000 +1.2%
Value US$17,310
2.8
Castelein Caley Non-Executive Director
Transaction date
Purchase
Price
14.55
Quantity 15,800 +3.2%
Value US$229,890
4.1
Kulkarni Sandeep Chidambar CEO Executive Director
Transaction date
Purchase
Price
12.25
Quantity 5,000 +0.7%
Value US$61,250
2.8
Castelein Caley Non-Executive Director
Transaction date
Purchase
Price
12.07
Quantity 4,200 +0.8%
Value US$50,694
3.9
Thiara Parvinder Non-Executive Director
Transaction date
Purchase
Price
12.12
Quantity 2,000 +2.5%
Value US$24,240
4.1
Kulkarni Sandeep Chidambar CEO Executive Director
Transaction date
Purchase
Price
10.68
Quantity 4,650 +0.6%
Value US$49,662
3.9
Thiara Parvinder Non-Executive Director
Transaction date
Purchase
Price
10.66
Quantity 5,000 +6.6%
Value US$53,300
3.2
KANTOFF AARON Non-Executive Director
Transaction date
Purchase
Price
11.86
Quantity 7,500 +19.8%
Value US$88,950
1.0
Requadt Scott Former Officer and Director Executive Director
Transaction date
Proposed sale
Price
3.08
Quantity 11,786
Value US$36,316
1.5
Fenton Mary Kay Officer Officer
Transaction date
Proposed sale
Price
3.08
Quantity 12,946
Value US$39,891
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.49
Quantity 12,942 -0.3%
Value US$32,244
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.56
Quantity 14,208 -0.4%
Value US$36,338
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.59
Quantity 16,870 -0.4%
Value US$43,725
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.46
Quantity 25,419 -0.7%
Value US$62,637
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.48
Quantity 40,642 -1.0%
Value US$100,772
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.39
Quantity 75,001 -1.9%
Value US$179,095
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.53
Quantity 25,549 -0.9%
Value US$64,596
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.52
Quantity 7,841 -0.3%
Value US$19,755
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.50
Quantity 15,818 -0.6%
Value US$39,616
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.56
Quantity 15,713 -0.6%
Value US$40,177
1.6
SUZANNE ILDSTAD Director Non-Executive Director
Transaction date
Proposed sale
Price
2.65
Quantity 250,000
Value US$662,500
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.35
Quantity 15,004 -0.5%
Value US$35,231
1.6
Suzanne Ildstad Officer Officer
Transaction date
Proposed sale
Price
2.39
Quantity 10,051
Value US$24,022
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.33
Quantity 46,990 -1.6%
Value US$109,313
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.16
Quantity 21,753 -0.7%
Value US$47,056
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.15
Quantity 49,211 -1.7%
Value US$105,804
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.14
Quantity 99,771 -3.3%
Value US$213,530
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.06
Quantity 10,436 -0.3%
Value US$21,543
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.06
Quantity 6,806 -0.2%
Value US$13,992
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.05
Quantity 29 -0.0%
Value US$59
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.05
Quantity 3,500 -0.1%
Value US$7,185
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.05
Quantity 3,612 -0.1%
Value US$7,406
1.6
Ildstad Suzanne Non-Executive Director
Transaction date
Sale
Price
2.06
Quantity 2,939 -0.1%
Value US$6,040
1.6
Ildstad Suzanne Chief Scientific Officer Officer
Transaction date
Sale
Price
2.80
Quantity 525,000 -14.6%
Value US$1,470,000
1.0
Requadt Scott Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.25
Quantity 39,382 +8.4%
Value US$167,374
1.0
Requadt Scott Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.25
Quantity 3,090 +0.7%
Value US$13,132
1.0
Requadt Scott Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.24
Quantity 5,528 +1.2%
Value US$23,439
1.0
Requadt Scott Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.75
Quantity 9,444 +2.1%
Value US$35,412
2.0
Nader Francois Non-Executive Director
Transaction date
Purchase
Price
3.72
Quantity 36,500 +35.8%
Value US$135,780
2.0
Nader Francois Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 52,000 +104.0%
Value US$188,240
2.0
Nader Francois Non-Executive Director
Transaction date
Purchase
Price
3.52
Quantity 50,000 +inf%
Value US$176,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-22 2024-08-21 B Purchase
4.1
Kulkarni Sandeep Chidambar

CEO

Executive Director
51,996 -8.6%
183.25
US$28,556 		51,996 -8.6% 183.25 US$28,556
2024-08-20 2024-08-16 B Purchase
4.1
Kulkarni Sandeep Chidambar

CEO

Executive Director
3,036 +17.1%
87.52
US$747,855 		3,036 +17.1% 87.52 US$747,855
2024-01-31 2024-01-29 B Purchase
1.5
MCDADE MARK
Non-Executive Director
18,004 -1.5%
202.93
US$4,823,918 		18,004 -1.5% 202.93 US$4,823,918
2023-11-20 2023-11-17 B Purchase
4.1
Kulkarni Sandeep Chidambar

CEO

Executive Director
4,000 +0.6%
16.99
US$67,960 		4,000 +0.6% 16.99 US$67,960
2023-11-20 2023-11-17 B Purchase
3.9
Thiara Parvinder
Non-Executive Director
1,000 +1.2%
17.31
US$17,310 		1,000 +1.2% 17.31 US$17,310
2023-10-27 2023-10-27 B Purchase
2.8
Castelein Caley
Non-Executive Director
15,800 +3.2%
14.55
US$229,890 		15,800 +3.2% 14.55 US$229,890
2023-10-26 2023-10-26 B Purchase
4.1
Kulkarni Sandeep Chidambar

CEO

Executive Director
5,000 +0.7%
12.25
US$61,250 		5,000 +0.7% 12.25 US$61,250
2023-10-27 2023-10-25 B Purchase
2.8
Castelein Caley
Non-Executive Director
4,200 +0.8%
12.07
US$50,694 		4,200 +0.8% 12.07 US$50,694
2023-10-26 2023-10-25 B Purchase
3.9
Thiara Parvinder
Non-Executive Director
2,000 +2.5%
12.12
US$24,240 		2,000 +2.5% 12.12 US$24,240
2023-10-26 2023-10-24 B Purchase
4.1
Kulkarni Sandeep Chidambar

CEO

Executive Director
4,650 +0.6%
10.68
US$49,662 		4,650 +0.6% 10.68 US$49,662
2023-10-26 2023-10-24 B Purchase
3.9
Thiara Parvinder
Non-Executive Director
5,000 +6.6%
10.66
US$53,300 		5,000 +6.6% 10.66 US$53,300
2023-10-26 2023-10-24 B Purchase
3.2
KANTOFF AARON
Non-Executive Director
7,500 +19.8%
11.86
US$88,950 		7,500 +19.8% 11.86 US$88,950
2023-07-05 2023-07-05 PrS Proposed sale
1.0
Requadt Scott

Former Officer and Director

Executive Director
11,786
3.08
US$36,316 		11,786 3.08 US$36,316
2023-07-05 2023-07-05 PrS Proposed sale
1.5
Fenton Mary Kay

Officer

Officer
12,946
3.08
US$39,891 		12,946 3.08 US$39,891
2023-06-14 2023-06-14 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
12,942 -0.3%
2.49
US$32,244 		12,942 -0.3% 2.49 US$32,244
2023-06-14 2023-06-13 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
14,208 -0.4%
2.56
US$36,338 		14,208 -0.4% 2.56 US$36,338
2023-06-14 2023-06-12 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
16,870 -0.4%
2.59
US$43,725 		16,870 -0.4% 2.59 US$43,725
2023-06-09 2023-06-09 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
25,419 -0.7%
2.46
US$62,637 		25,419 -0.7% 2.46 US$62,637
2023-06-09 2023-06-08 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
40,642 -1.0%
2.48
US$100,772 		40,642 -1.0% 2.48 US$100,772
2023-06-09 2023-06-07 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
75,001 -1.9%
2.39
US$179,095 		75,001 -1.9% 2.39 US$179,095
2023-06-07 2023-06-06 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
25,549 -0.9%
2.53
US$64,596 		25,549 -0.9% 2.53 US$64,596
2023-06-07 2023-06-05 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
7,841 -0.3%
2.52
US$19,755 		7,841 -0.3% 2.52 US$19,755
2023-06-05 2023-06-02 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
15,818 -0.6%
2.50
US$39,616 		15,818 -0.6% 2.50 US$39,616
2023-06-05 2023-06-01 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
15,713 -0.6%
2.56
US$40,177 		15,713 -0.6% 2.56 US$40,177
2023-06-01 2023-06-01 PrS Proposed sale
1.6
SUZANNE ILDSTAD

Director

Non-Executive Director
250,000
2.65
US$662,500 		250,000 2.65 US$662,500
2023-04-25 2023-04-21 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
15,004 -0.5%
2.35
US$35,231 		15,004 -0.5% 2.35 US$35,231
2023-04-21 2023-04-21 PrS Proposed sale
1.6
Suzanne Ildstad

Officer

Officer
10,051
2.39
US$24,022 		10,051 2.39 US$24,022
2023-04-21 2023-04-20 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
46,990 -1.6%
2.33
US$109,313 		46,990 -1.6% 2.33 US$109,313
2023-04-21 2023-04-19 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
21,753 -0.7%
2.16
US$47,056 		21,753 -0.7% 2.16 US$47,056
2023-04-19 2023-04-18 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
49,211 -1.7%
2.15
US$105,804 		49,211 -1.7% 2.15 US$105,804
2023-04-19 2023-04-17 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
99,771 -3.3%
2.14
US$213,530 		99,771 -3.3% 2.14 US$213,530
2023-03-20 2023-03-17 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
10,436 -0.3%
2.06
US$21,543 		10,436 -0.3% 2.06 US$21,543
2023-03-07 2023-03-03 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
6,806 -0.2%
2.06
US$13,992 		6,806 -0.2% 2.06 US$13,992
2023-03-02 2023-03-01 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
29 -0.0%
2.05
US$59 		29 -0.0% 2.05 US$59
2023-02-23 2023-02-21 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
3,500 -0.1%
2.05
US$7,185 		3,500 -0.1% 2.05 US$7,185
2023-02-21 2023-02-17 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
3,612 -0.1%
2.05
US$7,406 		3,612 -0.1% 2.05 US$7,406
2023-02-21 2023-02-16 S Sale
1.6
Ildstad Suzanne
Non-Executive Director
2,939 -0.1%
2.06
US$6,040 		2,939 -0.1% 2.06 US$6,040
2022-08-23 2022-08-22 S Sale
1.6
Ildstad Suzanne

Chief Scientific Officer

Officer
525,000 -14.6%
2.80
US$1,470,000 		525,000 -14.6% 2.80 US$1,470,000
2022-08-02 2022-07-29 B Purchase
1.0
Requadt Scott

Chief Executive Officer

Executive Director
39,382 +8.4%
4.25
US$167,374 		39,382 +8.4% 4.25 US$167,374
2022-07-28 2022-07-28 B Purchase
1.0
Requadt Scott

Chief Executive Officer

Executive Director
3,090 +0.7%
4.25
US$13,132 		3,090 +0.7% 4.25 US$13,132
2022-07-28 2022-07-26 B Purchase
1.0
Requadt Scott

Chief Executive Officer

Executive Director
5,528 +1.2%
4.24
US$23,439 		5,528 +1.2% 4.24 US$23,439
2022-07-26 2022-07-22 B Purchase
1.0
Requadt Scott

Chief Executive Officer

Executive Director
9,444 +2.1%
3.75
US$35,412 		9,444 +2.1% 3.75 US$35,412
2022-07-25 2022-07-21 B Purchase
2.0
Nader Francois
Non-Executive Director
36,500 +35.8%
3.72
US$135,780 		36,500 +35.8% 3.72 US$135,780
2022-07-25 2022-07-20 B Purchase
2.0
Nader Francois
Non-Executive Director
52,000 +104.0%
3.62
US$188,240 		52,000 +104.0% 3.62 US$188,240
2022-07-25 2022-07-19 B Purchase
2.0
Nader Francois
Non-Executive Director
50,000 +inf%
3.52
US$176,000 		50,000 +inf% 3.52 US$176,000
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
701 +0.4%
17.00
US$11,917 		701 +0.4% 17.00 US$11,917
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
3,507 +0.4%
17.00
US$59,619 		3,507 +0.4% 17.00 US$59,619
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
1,902 +0.4%
17.00
US$32,334 		1,902 +0.4% 17.00 US$32,334
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
2,917 +0.4%
17.00
US$49,589 		2,917 +0.4% 17.00 US$49,589
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
1,444 +0.4%
17.00
US$24,548 		1,444 +0.4% 17.00 US$24,548
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
3,611 +0.4%
17.00
US$61,387 		3,611 +0.4% 17.00 US$61,387
2021-05-14 2021-05-11 B Purchase
3.5
Clarus Lifesciences III, L.P.
Large shareholder
15,918 +0.3%
17.00
US$270,606 		15,918 +0.3% 17.00 US$270,606
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
701 +0.4%
17.00
US$11,917 		701 +0.4% 17.00 US$11,917
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
3,507 +0.4%
17.00
US$59,619 		3,507 +0.4% 17.00 US$59,619
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
1,902 +0.4%
17.00
US$32,334 		1,902 +0.4% 17.00 US$32,334
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
2,917 +0.4%
17.00
US$49,589 		2,917 +0.4% 17.00 US$49,589
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
1,444 +0.4%
17.00
US$24,548 		1,444 +0.4% 17.00 US$24,548
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
3,611 +0.4%
17.00
US$61,387 		3,611 +0.4% 17.00 US$61,387
2021-05-13 2021-05-11 B Purchase
Clarus Defined Exit I, L.P.
Large shareholder
15,918 +0.3%
17.00
US$270,606 		15,918 +0.3% 17.00 US$270,606
2021-05-11 2021-05-11 B Purchase
2.9
Longitude Capital Partners III, LLC
Large shareholder
235,000 +7.9%
17.00
US$3,995,000 		235,000 +7.9% 17.00 US$3,995,000
Explore more

More insider trading research around Tourmaline Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America